Lenskart Q2 FY27: consolidated PAT more than doubles YoY to ₹232 Cr, margins expand
PAT +124.65% YoY · revenue +35.73% · margins expanding
₹2,845.03 Cr
+35.73% YoY
₹232.45 Cr
+124.65% YoY
8.02%
+3.2pp YoY
₹1.31
Lenskart's consolidated revenue rose 35.7% YoY to ₹2,845 Cr (from ₹2,096 Cr) in Q2 FY27, with PAT (total, incl. minority interest) more than doubling to ₹232.45 Cr from ₹103.45 Cr — a 124.7% YoY jump, comfortably outpacing revenue growth. Sequentially the picture is milder: revenue grew 4.8% QoQ and PAT just 1.8% QoQ (from ₹228.43 Cr), consistent with the YoY-primary read this print should be judged on. No exceptional items sat in either the current or year-ago quarterly column, so the YoY growth is clean (unadjusted) — H1 FY26's ₹10.39 Cr one-off loss falls outside the quarterly comparison.
Q2 FY-2027 vs prior quarters
The margin story is an EBITDA bridge: consolidated EBITDA margin (EBITDA/revenue) rose to 21.86% from 19.77% a year ago, a ~210bps YoY expansion, while NPM (PAT/total income) widened to 8.02% from 4.86%. Sequentially EBITDA margin was roughly flat (+18bps vs Q1's 21.68%) while NPM actually dipped ~19bps QoQ, since total income grew faster (+4.2%) than PAT (+1.8%) this quarter. The real driver is segmental: international segment PBT jumped 212.7% YoY to ₹97.22 Cr (from ₹31.09 Cr) on revenue up 36.6% YoY, far outpacing the India segment's PBT growth of 65.3% YoY (₹208.42 Cr vs ₹126.07 Cr). That divergence also shows up between entities — standalone (largely India-entity) PAT grew 69.3% YoY to ₹167.85 Cr, materially slower than the 124.7% consolidated growth, underscoring that international subsidiaries (Owndays, and smaller stake additions in Le Petit Lunetier Paris and Dimension NXG this quarter) are now a growing share of group profit.
The stock went into the print at ₹693.65, up 0.1% over the past month of trading.
For context: this is the highest quarterly PAT in the last 5 quarters on our records; PAT has now risen for 4 consecutive quarters; revenue is at a 5-quarter high.
What the summary numbers don't show
Basic EPS ₹1.31 vs ₹0.61 YoY (+114.8%) and ₹1.28 QoQ (+2.3%)
Long-term target ~25% EBITDA margin maintained (aspirational). No FY27 revenue/margin guidance. Store expansion to continue; international acceleration planned for coming years after tech integration. Quarterly margins to vary with seasonality and store opening phasing.
Management gave no formal FY27 revenue or margin guidance on the last call — only a long-term, aspirational ~25% EBITDA margin target, with quarterly margins flagged as likely to vary with seasonality and store-opening phasing; against that backdrop this quarter's 21.86% margin is continued progress but still below the aspirational level, so vsGuidance reads as unknown/not formally testable rather than a clean beat. No verified pre-result street consensus (PAT/revenue estimates) for this specific quarter turned up in search, so vsStreet is unknown — none should be assumed. No company press release commentary was available in the record to cross-check management's own framing of the print. Among the quarter's other disclosed developments, a ₹13.17 Cr customs duty and penalty order (Oct 16, 2026) is immaterial against the scale of this result, and the SVF II Lightbulb stake sale (4.5 Cr shares) and Platinum Jasmine Trust's 2.01% stake sale are shareholding-pattern events with no P&L bearing this quarter.
W1
EBITDA margin trajectory toward management's long-term ~25% aspirational target (currently 21.86%, up from 19.77% a year ago)
W2
Durability of international segment PBT growth (+212.7% YoY) as Owndays integration and planned 'international acceleration... after tech integration' (per last concall) progresses
W3
Store expansion pace and its effect on segment PBT phasing, which management flagged as a source of quarterly margin variability
Consol. PBT includes ₹1.79 Cr share of JV/associate profit (no exceptional item this quarter or year-ago quarter). Consol. PAT 232.45 Cr is total; owners' share 227.68 Cr, NCI 5.37 Cr. Both statements legible and fully reconcile.
Lenskart Q2: Momentum Hold – Watch for Margin Durability
Strong Q1 resets expectations. The Street's test in Q2 is whether 18% same-store sales growth, 21.7% EBITDA margins, and 43% revenue momentum persist, or whether growth normalizes as comparables stiffen.
What to expect in Q2
~₹35–37 Cr
Q1 was ₹27.14 Cr (+43% YoY); Q2 typically slightly weaker seasonally; 30–35% YoY growth keeps Street's 28% FY27 target on track
~16–19%
Q1 delivered 18.3% SSSG; pricing power and product mix (rising frame ASPs) remain structural, but watch for deceleration on tougher comps
~21–22%
Q1 hit 21.7% (a 400bp jump YoY); operating leverage from store productivity and higher-margin product mix intact; customs duty hit may weigh margins by 10–15bp
~38% YoY growth (on-plan)
Q1 international revenue ₹12.03 Cr (+38%); growth driven by Lenskart Direct expansion and currency tailwinds; watch for guidance update on capex/store rollout
A strong Q2 means SSSG stays above 17%, revenue hits ₹36+ Cr, and EBITDA margin holds above 21% (ex-the customs duty charge). A weak Q2 means SSSG slides into low-teens, revenue undershoots ₹34 Cr, or margin compression signals operating deceleration. The bar is high: Q1's beat has brought all analysts into consensus by mid-year.
Is the company on track to its full-year plan?
Yes, with caveats. Q1 delivered ₹27.14 Cr revenue (+43% YoY) and ₹2.28 Cr PAT (+269% YoY), both well ahead of a 28% full-year growth consensus. Lenskart's own FY27 revenue guidance is unverified in the DB (no Q1 call transcript available), but the Street consensus of ₹11.29k Cr (₹112.9 Cr annualized, +28.1% YoY) is within reach if H2 moderates to 20–25% growth. EBITDA margins at 21.7% in Q1 suggest the business has crossed into sustainable profitability — not a temporary spike — driven by (i) store maturation and same-store sales growth, (ii) higher-margin direct channels (online + international), and (iii) cost leverage. Risks: FY27 comparables will harden in H2; international capex plans could pressure margins if guidance escalates.
What the Street says
Since Q1: What's changed
1 · Customs duty order (₹13.17 Cr)
Oct 16: Principal Commissioner of Customs issued a demand for ₹13.17 Cr in duties and penalties. This is a one-off headwind to Q2 net profit (~2–3% of quarterly PAT) and may reflect legacy import classification disputes. Immaterial to operating trajectory, but worth flagging in Q2 guidance.
2 · FII inflows signal confidence
FII holding jumped 800bp QoQ (Q1 FY27 12.76% vs. Q4 FY26 4.26%) — one of the largest institutional moves. Institutional flows typically lead earnings surprises; this suggests the Street is priced for upside.
3 · Promoter stake: steady (~17.5%)
No significant promoter trading. Platinum Jasmine trust exited 2.01% in late Sep (at ₹683), and SVF II Lightbulb (Softbank) sold 2.59% in Aug — both signaling supply, not insider concern. Routine portfolio rebalancing at high valuations.
4 · International JV activity ramping
Le Petit Lunetier (France), Dimension NXG (Ajna), China/Korea subs all saw stake increases or new formations in Aug–Sep. These are strategic but not material to Q2; watch for capex guides in Q2 call.
5 · Insider trading window closed
Standard pre-result window closure (Sep 25 through 48h post-announcement). No signals here.
Close: The setup
Lenskart walks into Q2 with momentum and raised expectations. Q1's 43% revenue growth and 269% PAT jump have reset the baseline; the Street now prices a flawless H2. The real test is whether the profitability story (21.7% EBITDA margins driven by store maturation and same-store sales growth) is structural or a sugar rush from low comps and currency. A strong Q2 means SSSG holds 17%+, margins expand or at least hold, and management re-guides full-year growth to 30%+ on the back of international momentum. A weak Q2 — SSSG in low-teens, margin compression, or guidance cut — would be a disappointment to consensus.
Three things to watch on Nov 4: (1) SSSG trajectory — is 18% sustainable, or does it decel into mid-teens? (2) EBITDA margin guidance for H2 and FY27 — will customs duty and international capex pressure it? (3) International business guidance and capex plans — is this a ₹1 Cr revenue business by FY28, or a multiyear playbook?
Growth Real, Margins Deferred — the Q2 Trade-Off
Revenue and profit both delivered and beat, but sequential momentum stalled. Management is explicit: reinvestment now, margins later. The question is whether that trade pays off.
Lenskart delivered on headline numbers — revenue and profit both matched or beat prior-call claims. But the quarter tells two stories. Year-over-year, the business is firing: revenue +35.7%, PAT +124.7%, operating margin up 280 basis points. Quarter-over-quarter, it has stalled: revenue +4.8%, PAT +1.8%. The company explains this openly: it is investing hard into volume and brand (John Jacobs, Meller, OWNDAYS, Hustlr, smart glasses) at the expense of near-term profit. That is a deliberate choice, not a miss. The harder question is whether it will pay off.
₹2,845 Cr
+35.7%
₹232 Cr
+124.7%
+4.8%
seasonal moderation
+1.8%
growth decelerating
Claims vs. reality
What changed on this call
Margin timeline pushed to indefinite. Q1 set a long-term target of ~25% EBITDA margin (described as aspirational). Q2 reiterated the target but explicitly deferred it: 'will not put a timeframe on 25%.' Management is clear — margins are secondary to volume and market share for the next several quarters. Current OPM is 21.9%; EBITDA margin (pre-IndAS basis) sits at 13.8%. The gap reflects heavy marketing spend (brand launches, campaigns, Hustlr subsidies) and capex intensity (₹484 Cr H1: ₹187 Cr store network, ₹297 Cr plant).
International economics are proving stronger. International segment posted 29.5% YoY growth (23% constant currency), with EBITDA (pre-IndAS) at ₹127 Cr (+87% YoY) and margin of 10.6% vs 7.3% prior year. Product margin expanded to 77.1%, driven by OWNDAYS and Meller integration. This is a strategic win — it proves the international platform can generate acceptable returns at this scale (38 new stores in H1). Management remains cautious on pace ('slowly and steadily') but Hyderabad capacity expansion is underway.
Hustlr and smart glasses elevated to core strategy. Hustlr (₹500 affordable eyewear) was first mentioned this quarter. Management characterizes it as early-stage but scaling ('Tier 2, Tier 3, logistics to 10K stores'). In-house manufacturing (frames +20% CAGR, lenses +52% QoQ) is the enabler. Lenskart evolv (smart glasses) similarly moved from concept to pilot; 934 stores now have remote optometry capability, enabling 1 store/day openings in Tier 2+. Neither has proven unit economics; both are strategic bets on volume and moat-building.
How the street is positioned
The stock closed at ₹718.80 near its all-time high of ₹760.75, implying the market is pricing in the growth story. Trend is bullish, trading above SMA20/50/200. RSI is 62.5 (neutral, not overbought). Critically, institutional flows are accelerating: FII ownership surged from 3.86% in Q3 FY26 to 12.76% in Q1 FY27 — a +8.5pp jump in two quarters. DII similarly moved from 15.86% to 23.57% (+8.09pp). Bulk deals in late August showed active accumulation by BlackRock, Edelweiss, and Susquehanna in the ₹630–662 range, while a promoter-linked trust (Platinum Jasmine) sold at ₹683 in late September. The institutional inflow pattern suggests confidence in the growth thesis, though the stock's proximity to its all-time high leaves little room for valuation multiple expansion.
YoY revenue +35.7%, PAT +124.7% — sustained momentum confirmed
India SSS +20.8%, pin codes +27.1% — broad-based growth
Operating margin expanded 280bp YoY via in-house manufacturing
International margins +87% EBITDA, 10.6% pre-IndAS — threshold crossing
Remote optometry + AI in 934 stores — structural moat deepening
QoQ PAT +1.8% — growth decelerating sharply
Margin timeline pushed to indefinite — near-term upside capped
FX headwind (₹14.2/RMB) drives 25%+ COGS inflation on imports
Six concurrent brand launches — management bandwidth stretched
Stock at ATH on growth; limited valuation cushion
Risks, ranked by how much they should concern a holder
Forex headwinds (INR/RMB at ₹14.2 vs ₹11–12 prior)
High25%+ COGS inflation on imported frames and lenses. In-house manufacturing (Bhiwadi, Manesar, Thailand) and Tier 2+ India production provide partial offset, but margin compression is structural until INR stabilizes.
Margin deferral with no timeline (25% EBITDA target)
HighManagement explicitly won't quantify when margin expansion resumes. Investors expecting near-term profit leverage will be disappointed. Current OPM 21.9% may plateau before reinvestment moderates.
Execution on simultaneous brand scaling (6+ brands)
MediumJohn Jacobs, Meller, OWNDAYS, Shunya, Hustlr, Lenskart evolv all in growth/launch phase. Management bandwidth and capex spread thin. Success unproven at scale.
Competitive response to Hustlr ₹500 value offering
MediumHustlr targets untapped TAM but draws competitor response. Margin protection depends on in-house manufacturing at 75% automation; economics at ₹500 ASP unproven at 10M+ unit scale.
International expansion logistics and capex intensity
MediumTarget 100M+ pairs, 10K+ stores globally. Hyderabad capacity is acknowledged bottleneck. 38 new stores H1 is aggressive; cash flow covers capex now but scale-up risk is real.
QoQ growth deceleration (PAT +1.8% vs +35.7% YoY)
LowSequential slowdown may reflect H1 front-loading or seasonal moderation post-Diwali. Trailing 12M PAT ₹800 Cr is still strong. But if H2 sustains low QoQ growth, full-year trajectory is at risk.
What to watch next
1 · H2 organic growth trajectory
QoQ PAT +1.8% is a red flag. If Q3 QoQ growth remains single-digit, the growth story is cracking. Look for revenue growth and same-store sales to re-accelerate; if they don't, the margin-deferral thesis loses credibility.
2 · Hustlr scale-up and unit economics proof
Early indicator of whether ₹500 value glasses can drive 10M–100M unit TAM without margin collapse. Next call should show uptick in Hustlr units and AOV metrics that prove economics are viable at planned scale.
3 · FX relief or structural mitigation
If INR/RMB remains at ₹14.2+, in-house manufacturing will be critical. Watch capex allocation to Bhiwadi/Manesar and announcements on India/Thailand lens/frame production scaling. If no relief by Q3, COGS inflation is permanent and margin ceiling is lower.
Lenskart is executing a bet: sacrifice near-term profit for market share and moat-building. The numbers support the growth half — revenue, volumes, international economics all moving. The question is whether the cost of reinvestment is worth it. Management is betting on Tier 2+ densification, Hustlr scale, international inflection, and smart glasses adoption to deliver 25%+ EBITDA margins, explicitly refusing to quantify a timeline. Institutions are betting too — FII ownership +850bp in two quarters signals confidence. But the stock is at its all-time high and margins are deferred indefinitely. Risk-reward is balanced, not convex. Growth is steady; margins are contingent. The number to track is organic ROCE — if capital deployed in Hustlr, international, and evolv generates 18%+ returns, the deferral thesis holds. If returns stall, the stock will not appreciate until reinvestment slows. At ₹718, this is a disciplined hold for long-term growth believers, not a near-term trade.
Strong growth but margin upside deferred; execution tracking well
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Met quarterly delivery. Guidance on 25% margin reaffirmed but timeline pushed to indefinite future ('years not quarters').
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong YoY growth (+35.7% revenue, +124.7% PAT) and margin expansion corroborate operational momentum. However, QoQ deceleration (PAT +1.8%, revenue +4.8%) and management's explicit deferral of 25% margin timeline signal profit growth will be sacrificed for market share. Mid-cap execution risk on simultaneous brand building (John Jacobs, Meller, OWNDAYS) and international expansion.
₹2845 Cr
Revenue · +35.7% YoY₹232.4 Cr
Reported PAT · +124.7% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
Revenue ₹2,845 crores, grew 32.5% YoY
METDelivered ₹2,845 Cr confirmed; YoY growth 35.7% vs 32.5% claimed
PAT more than doubled to ₹232 crores
METPAT ₹232.4 Cr, +124.7% YoY — exactly as claimed
EBITDA grew to ₹624 Cr, margin 13.8%
METOperating profit matches ₹623 Cr; margin 21.9% (OPM) vs 13.8% cited (likely EBITDA pre-IndAS/different basis)
Same-store sales growth 20.8%
METDelivered result confirms SSS momentum; claim supported by operational metrics
Eye tests grew 44% to 70 lakhs; units +26.5% to 86 lakhs
METInternally consistent with segment growth trajectory; volume metrics credible
Earnings quality
What changed since the last call
25% margin timeline pushed out
NeutralPrior: 'long-term target ~25%' (Q1). Q2: 'will not put a timeframe on 25%' — no exit date, explicitly deferred.
International margins expanded
UpgradeIntl product margin 75.5% → 77.1% YoY via OWNDAYS/Meller integration; EBITDA pre-Ind-AS ₹127 Cr, +87% YoY, 10.6% margin vs 7.3% prior year.
Hustlr confirmed as major bet
NewQ1 not mentioned; Q2 call emphasizes ₹500 affordable glasses, early journey, scaling logistics. Not undercutting strategy yet.
Remote optometry and AI eye test deployment
New934 stores now have remote optometry; Drysh (AI-assisted) in pilot. Management calls it 'breakthrough' for scale; eye test growth 44% YoY to 70L.
The Q&A
Analysts pressed hard on margin trajectory (Devansh Bansal, Harit). Management held firm: invest first, margins later. On ASP — acknowledged Hustlr and campaigns depress realization; countered that units-per-customer +1.8→1.9 shows quality. On international — capacity constraints acknowledged; Hyderabad video shown as mitigation. No major dodges, but tone was 'explain not apologize.'
Margin trajectory — Devansh Bansal, Emkay Global
AnsweredMargins positively correlated with volume. Focus is on volume growth, will continue marketing investments. 12-month view shows expansion, but quarterly fluctuates with campaigns and seasonality.
Realization per piece — Mihir Shah, Nomura
PartialProgressives show strong uptick via digitized measurement. ASP varies by campaign mix. Hustlr at ₹500 anchors low-end; units-per-customer improving (1.8→1.9) shows quality. Not guiding specific realization number.
AI eye test unlock — Arnab Mitra, Goldman Sachs
AnsweredRemote optometry critical unlock — enables 1 store/day opening in Tier 2+. AI (Drysh) can fill gaps. Hyderabad is bottleneck; investing and accelerating capacity. Will manage growth pace.
Hustlr trajectory — Ashish Kanodia, Citi
AnsweredNascent, early. Excited by response but managing logistics for scale (Tier 2, Tier 3, logistics to 10K stores). Lots of work ahead. Will show impact over time.
Lenskart evolv smart glasses — Amit Purohit, Elara Securities
PartialPilot stage, learning consumer experience. Not undercutting majority of players — raising bar on experience, not price. Very early to comment on ASP. Focused on software/firmware capability and brand experience.
Gross margin pressure — Harit Kapoor, Investec
AnsweredFX is major factor (INR ~₹14.2/RMB vs ~₹11-12 prior) — imported components hurt COGS. Structural offset: backward integration (in-house frames, lenses in India/China/Thailand). Vendor scale improving. Natural hedge at Group level (40% revenue non-INR).
Tier 2+ cities unit economics — Latika Chopra, JP Morgan
AnsweredValue creation in Tier 2+ is superior to metros. Slower growth initially but similar trajectory. Brands (OWNDAYS, John Jacobs) at premium scale, Lenskart at standard, Hustlr anchors affordability. Not differentiating pricing by tier yet, but economics improve with scale and operations efficiency.
Smart glasses demand — Aditya Soman, CLSA
AnsweredSlow and steady. Soft launch April this year with signup list. Learned a lot on feature requests. 90% buying with prescription, ~every 2 weeks software updates in stores. Adoption growing daily, but early and multi-year journey. No undercut strategy — building ecosystem.
Guidance
No FY27 numeric revenue target; organic growth to continue
MediumQ1 call gave no FY27 guidance. Q2 reaffirms strategy (Tier 2+ expansion, international, Hustlr, smart glasses). No exit guidance but trajectory clear.
Long-term EBITDA margin ~25% (aspirational); no timeframe given
MediumQ2 EBITDA margin 13.8% by call metric (OPM 21.9% delivered). Management: 'years not quarters. Quarterly numbers might move, direction will not.' Expects ongoing campaigns, seasonality to cause Q volatility.
Continue store expansion (165 stores this quarter); plant investments ongoing
HighH1 capex ₹187 Cr for store network, ₹297 Cr plant. Management confident in Hyderabad scaling; international 'slowly and steadily.' No numeric capex target but trajectory clear.
Risks the call surfaced
Forex headwinds
HighINR depreciation vs RMB (₹14.2 now vs ~₹11-12 prior) drives 25%+ COGS inflation on imported frames/lenses. Impact on international segment COGS. Hedge strategy not disclosed.
Execution risk (brand scaling)
MediumManagement launching/scaling 6+ brands/concepts concurrently: John Jacobs, Meller, OWNDAYS, Shunya, Hustlr, Lenskart evolv. Capex and management bandwidth stretched. Success unproven at scale.
Competitive intensity (value segment)
MediumHustlr targets ₹500 affordable glasses with high-quality frame/lens/fitting. Competitors may copy or undercut. Margin protection unclear at volume scale.
International expansion pace
MediumTarget 100M+ pairs/10K+ stores globally. Requires ₹297 Cr+ annual plant capex, logistics to 38 new stores/year (H1 pace). Hyderabad capacity is acknowledged bottleneck.
QoQ growth deceleration
LowRevenue QoQ +4.8%, PAT QoQ +1.8% vs YoY +35.7%, +124.7%. Suggests H1 had front-loaded growth or Q2 seasonal moderation. H2 growth trajectory uncertain.
Management
Score 7/10. Clear on strategy (engineering-first, vertical integration, brand portfolio). Transparent on challenges (FX, capex intensity, execution complexity). Defers near-term margin timeline ('years not quarters') which may frustrate growth-focused investors, but honest. Hit Q2 targets (₹2,845 Cr revenue, ₹232 Cr PAT). Store expansion on pace (165 adds), EBITDA margin expanded 2.6pp. H1 PAT 87% of full-year FY26, tracking strong full-year growth. Track record: met Q1 delivery, no guidance misses in H1.
1 · H2 FY27
Store network expansion (Tier 2+ densification, international Hyderabad capacity)
2 · FY28
Hustlr scale-up and Lenskart evolv smart glasses adoption trajectory
3 · H1 FY28
EBITDA margin recovery if reinvestment moderates or volumes accelerate materially
Mid-cap execution risk on simultaneous brand building (John Jacobs, Meller, OWNDAYS) and international expansion.